Doctor and Advocacy Groups Work to Deliver Cervical Cancer Vaccinations
October 16, 2006
The Partnership to End Cervical Cancer (PECC) is a group of more than 20 member organizations dedicated to ensuring the immediate inclusion of cervical cancer vaccines as part of routine preventive health care for American women. Cervical cancer, mostly caused by persistent infection with oncogenic human papillomavirus (HPV), is the second most prevalent cancer among women. It takes the lives of more than 270,000 women worldwide each year.
"This partnership is inspired by the enormous opportunity a vaccination will offer to help eliminate most forms of cervical cancer, but we are concerned that the public health landscape is not primed to ensure broad access to vaccines," said Phyllis Greenberger, chairperson of PECC. "Our goal is to educate women about cervical cancer and to encourage the public health network, physicians, and policymakers to take action to ensure that women have access to medical breakthroughs, such as new vaccines."
The PECC members have formed four committees to address policy and public health challenges to securing access to vaccines for women:
"That we can potentially eliminate most forms of a cancer through a series of vaccinations is a significant milestone in health care history," said Dr. Stanley Gall, an American College of Obstetrics and Gynecologist representative who serves on and advises partnership committees.
Women's Health Weekly
New Jersey Senate Committee Approves Measure That Would Establish Needle-Exchange Program in Six Cities
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.